IMI2-2017-13-10
IMI2-2017-13-10
1 project · €5,331,000 total EU contribution (project-level) · 18 participating organizations · 12 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€5,331,000
Countries active
Participant organizations by country (headquarters in CORDIS).
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- BIOVISTA1 projects · EL
- ALCEDIAG1 projects · FR
- ASTRAZENECA AB1 projects · SE
- FACULTY OF PHARMACY UNIVERSITY OF BELGRADE1 projects · RS
- FCDI1 projects · US
- ICETA1 projects · PT
- INTE:LIGAND SOFTWARE-ENTWICKLUNGS-UND CONSULTING GMBH1 projects · AT
- UNIVERSITY OF EASTERN FINLAND (UEF)1 projects · FI
- MEDIZINISCHE UNIVERSITAET WIEN1 projects · AT
- MERCK SHARP & DOHME CORP1 projects · US
- NOVARTIS1 projects · CH
- PFIZER1 projects · UK
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRisk · 821528 | H2020 | €5,331,000 | €816,313 | Details |